Tag Archives: Epilepsy

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Vagus Nerve Stimulation (VNS) Devices Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Vague Nerve Stimulation (VNS) Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vague Nerve Stimulation (VNS) Devices Market: By Product Type ( Implantable VNS Devices and External VNS Devices ), By Application ( Depression, Epilepsy, and Migraine ), By End User ( Hospitals, Ambulatory Surgical Centers (ASCS), and Others) , and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vague Nerve Stimulation (VNS) devices market valued at US $ XX Mn in 2017 and is expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Vagus Nerve Stimulation (VNS) Devices Market

Vagus nerve stimulation process involves implantation of a device that stimulates the vagus nerve with electrical impulses. The vagus nerves are a pair of nerves that start in the brain and run through the body. This is a nervous play in the conversation between the brain and the body. The vagus nerve stimulation is most often used to treat epilepsy. Vagus nerve stimulation devices are designed to prevent seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. Vagus nerve stimulation device is sometimes referred to as a „pacemaker for the brain.“ The device is placed under the skin on the chest and a wire runs from it to the vagus nerve in the neck.

 

Market Dynamics: Vagus Nerve Stimulation (VNS) Devices Market

According to the WHO, 4.5% -11% of all illnesses. The increasing prevalence of neurological disorders such as migraine and epilepsy among all age groups is expected to drive the market revenue growth. The increasing R & D activities, favorable reimbursement policies are expected to fuel the growth of the Vagus Nerve Stimulation (VNS) devices market. However, the higher treatment costs may be the growth of the market. According to the Epilepsy Foundation, VNS therapy currently costs approximately $ 30,000.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Vagus Nerve Stimulation (VNS) Devices Market

Vagus Nerve Stimulation (VNS) devices market is segmented based on the product type, by application, and end user

Based on the product type, the market is segmented into the following:

  • Implantable VNS Devices
  • External VNS Devices

Based on the application, the market is segmented into the following:

  • Depression
  • Epilepsy
  • Migraine

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Vagus Nerve Stimulation (VNS) Devices Market

Geographically, global vagus nerve stimulation (VNS) devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Vagus nerve stimulation (VNS) devices market is the fastest growing region. The increasing prevalence of the neurological disorders and the rise in the adoption of the VNS devices for the treatment of various neurological disorders expected to add fuel the market revenue growth. European market stands next to the North America market. Asia Pacific is the region expected to offer lucrative opportunities owing to rapid development in healthcare technology with a huge patient pool.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Vagus Nerve Stimulation (VNS) Devices Market

Some of the players in the global vagus nerve stimulation (VNS) devices market include:

  • LivaNova PLC (UK)
  • EnteroMedics Inc. (US)
  • ElectroCore Medical LLC (US)
  • Boston Scientific Corporation (US)
  • Cyberonics, Inc. (US)
  • NeuroMetrix, Inc.(US)
  • ImThera Medical (US)
  • Inspire Medical Systems, Inc.(US)

 

Notable Market Developments: Vagus Nerve Stimulation (VNS) Devices Market

  • In October 2017, LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, received U.S. Food and Drug Administration (“FDA”) approvals for its latest Vagus Nerve Stimulation Therapy (“VNS Therapy”) System, which consists of the SenTiv implantable generator and the next-generation VNS Therapy Programming System for the treatment of patients with drug-resistant epilepsy.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): 1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesellschaft/Politik Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Global Vagus Nerve Stimulation (VNS) Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Vagus Nerve Stimulation (VNS) Devices Market: By Product Type (Implantable VNS Devices and External VNS Devices), By Application (Depression, Epilepsy, and Migraine), By End User (Hospitals, Ambulatory Surgical Centers (ASCS), and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vagus Nerve Stimulation (VNS) devices market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Vagus Nerve Stimulation (VNS) Devices Market

Vagus nerve stimulation process involves implantation of a device that stimulates the vagus nerve with electrical impulse. The vagus nerves are a pair of nerves that start in the brain and run through the body. These nerves play a major role in receiving messages between the brain and the body. The vagus nerve stimulation is most often used to treat epilepsy when other treatments haven’t worked. Vagus nerve stimulation devices are designed to prevent seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. Vagus nerve stimulation device is sometimes referred to as a „pacemaker for the brain.“ The device is placed under the skin on the chest wall and a wire runs from it to the vagus nerve in the neck. The vagus nerve travels through neck and passes between the chest and abdomen and the lower part of the brain.

 

Market Dynamics: Vagus Nerve Stimulation (VNS) Devices Market

According to the WHO, neurological disorders are responsible for 4.5%-11% of all illnesses. The Increasing prevalence of neurological disorders such as migraine and epilepsy among all age groups is expected to drive the market revenue growth. The increasing R&D activities, favorable reimbursement policies are expected to fuel the growth of the Vagus Nerve Stimulation (VNS) devices market. However, the higher treatment costs may hinder the growth of the market. According to the Epilepsy Foundation, VNS therapy currently costs approximately USD 30,000.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Vagus Nerve Stimulation (VNS) Devices Market

Vagus Nerve Stimulation (VNS) devices market is segmented based on the product type, by application, and end user

Based on the product type, the market is segmented into the following:

  • Implantable VNS Devices
  • External VNS Devices

Based on the application, the market is segmented into the following:

  • Depression
  • Epilepsy
  • Migraine

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Vagus Nerve Stimulation (VNS) Devices Market

Geographically, global vagus nerve stimulation (VNS) devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Vagus nerve stimulation (VNS) devices market is the fastest growing region. The increasing prevalence of the neurological disorders and the rise in the adoption of the VNS devices for the treatment of various neurological disorders expected to add fuel the market revenue growth. European market stands next to the North America market. Asia Pacific is the region expected to offer lucrative opportunities owing to rapid development in healthcare technology with a huge patient pool.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Vagus Nerve Stimulation (VNS) Devices Market

Some of the players in the global vagus nerve stimulation (VNS) devices market include:

  • LivaNova PLC (UK)
  • EnteroMedics Inc. (US)
  • ElectroCore Medical LLC (US)
  • Boston Scientific Corporation (US)
  • Cyberonics, Inc. (US)
  • NeuroMetrix, Inc.(US)
  • ImThera Medical (US)
  • Inspire Medical Systems, Inc.(US)

 

Notable Market Developments: Vagus Nerve Stimulation (VNS) Devices Market

  • In October 2017, LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, received U.S. Food and Drug Administration (“FDA”) approvals for its latest Vagus Nerve Stimulation Therapy (“VNS Therapy”) System, which consists of the SenTiv implantable generator and the next-generation VNS Therapy Programming System for the treatment of patients with drug-resistant epilepsy.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

Pressemitteilungen

Brussels, May 23: Scientific Conference epiXchange2018

Seven large EU-funded projects have joined forces – epiXchange 2018 brings together Europe’s best brains to pave the way for future epilepsy research.

Brussels, May 23: Scientific Conference epiXchange2018

Scientific Conference epiXchange 2018, May 23, 2018, Brussels

Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease this figure and pave the way for future ground-breaking epilepsy research, seven large EU-funded projects have joined forces. epiXchange 2018 is a unique global community building event, designed to gather a critical mass of epilepsy researchers to exchange about latest progress in research aiming to improve the way epilepsy is diagnosed and treated and thereby increase the quality of life of affected people. Six of these projects were funded through the 7th Framework Programme (FP7) which provided total funding of EUR 52 million.

Despite a great progress in the management of epilepsy, 30-40% of epilepsy patients are refractory to all available medications.
Moreover, about 50% of children with epilepsy suffer from epilepsy-related co-morbidities, including developmental delay, learning disabilities, and autism spectrum disorder. Diagnostics is another issue.
„Diagnosis of epilepsy is really difficult,“ explained Prof. David Henshall, coordinator of the epiXchange 2018 co-organising EpimiRNA project. „Seizures are the main clinical symptom for the disease but it is very rare that a doctor will witness the patient having a seizure.“

New innovative solutions to diagnose and treat epilepsy

As published in HORIZON – The EU Research & Innovation Magazine on February 12, one of the major results from the epiXchange projects is the development of biomarkers for epilepsy diagnosis. Identifying biomarkers and changes to brain structures may ultimately lead to new treatments.
„Combining biomarkers is key,“ said Prof. Merab Kokaia, coordinator of the co-organising EPITARGET project. „It could make treatment more personalised in the years to come. Another interesting result as published in HORIZON on April 6 is the fact that delaying epilepsy onset through preventive medication in children with related disorders could reduce the impact on development of epilepsy and other related symptoms.
„If you have a brain malformation… there is nothing you can do to revers it. But… if you can prevent epilepsy from aggravating the situation you can improve the clinical status of these patients“, said Renzo Guerrini, coordinator of the co-organising DESIRE project.
Efforts have been made to pin down the genetics behind the disorders. Blood samples of babies at four key moments – at birth, when the EEG first begins to pick up problems, when seizures begin and at two years of age may help us to develop new drugs.
„We have a very, very unique situation. For the first time we have access to the molecular story before epilepsy“, said Prof. Sergiusz Jozwiak, coordinator of the co-organising EPISTOP project.

These findings and many others will be showcased at epiXchange. To boost the impact of the event, the epiXchange partners are preparing a white paper, presenting the current state of the art in epilepsy research, major bottlenecks and recommendations to shape the way for further research breakthroughs, to move forward to new ways of treatment and to bring research results closer to clinical application.

Five major areas

The epiXchange 2018 scientific conference focuses on five major themes in epilepsy research:

Genetics:
Development of novel treatment strategies based on optogenetics, gene and stem cell therapies.

Therapeutics:
Development of effective epileptogenic therapeutics, many of which face different kinds of bottlenecks e.g. regulatory hurdles.

Biomarkers:
Identification of new biomarkers in blood, peripheral organs, brain tissue, electrophysical data, behavioural data and imaging data, in order to develop novel preventive strategies in at-risk patients.

Biobanks and databases:
Integration of Biobanks and databases into clinical care to facilitate preclinical research. A collaborative approach as foundation for the future of epilepsy research and other disease model biobanks.

Co-morbidities:
Exploration of the mechanisms underlying bi-directional relations between epilepsy and neurological co-morbidities to reduce the high burden of co-morbidities in epilepsy.

epiXchange 2018 is is a dissemination activity of the FP7 funded projects DESIRE, EpimiRNA, EpiTarget and EPISTOP and is open for scientists, EC representatives, industries and other stakeholders from the epilepsy community as well as the press.

epiXchange 2018 key data
Organisers: DESIRE, EpimiRNA, EPISTOP and EpiTarget; Scientific contributions by EpiCare, EpiPGX and Epixchange
Venue: THE EGG, Brussels, www.theeggbrussels.com
Date: May 23, 2018
Homepage: www.epiXchange2018.eu
Twitter: www.twitter.com/epiXchange
Facebook: www.facebook.com/epiXchange2018/

Seven large EC-funded projects on epilepsy co-organise this conference to disseminate project results and discuss the future of epilepsy research in the EU and worldwide.

Six of these projects were funded through the 7th Framework Programme (FP7) which provided total funding of EUR 52 million.

Four of the projects (DESIRE, EpimiRNA, EPISTOP and EpiTarget), still ongoing FP7 collaborative research projects, are co-financing the event. Scientific contributions are provided by partners from EpiCare, an ongoing reference network project, as well as EpiPGX (FP7 collaborative research project) and Epixchange (FP7 MSCA ITN project), which are now finished.

Contact
ARTTIC S.A.S
Sebastian Vinzenz Gfäller
Oskar-von-Miller-Ring 29
80333 München
Phone: +49-89 248 83 03 -36
E-Mail: gfaeller@arttic.eu
Url: http://www.arttic.eu

Gesundheit/Medizin

Global Electroencephalography Equipment Market is Predicted to Grow at a CAGR of 7.34% during the 2015-2019

Global Electroencephalography Equipment Market 2015-2019 Size and Share Published in 2015-10-14 Available for US$ 2500 at Researchmoz.us

Description

About electroencephalography equipment

An electroencephalogram (EEG) is a technique used to detect electrical activity in the brain using electrodes that are attached to the scalp. Brain cells are active all the time and communicate via electrical impulses, even when individuals are asleep. These changes in the brain activity are recorded on an EEG as wavy lines, which are useful in the diagnosis of brain disorders. EEG is used as a diagnostic test for chronic brain disorders such as epilepsy, brain tumor, head injury, brain dysfunction, encephalitis, stroke sleep disorders, and dementia. EEG equipment is also used to confirm brain death in a persistent coma. According to WHO, the worldwide prevalence of epilepsy was estimated to be 50 million in 2014, with approximately 80% of epilepsy patients residing in countries with low and middle income. Every year, close to 2.4 million people are diagnosed with epilepsy. The use of EEG equipment is also increasing along with continuous EEG monitoring in ICUs and long-term EEG monitoring for epilepsy.

Technavio’s analysts forecast the global electroencephalography equipment market to grow at a CAGR of 7.34% during 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global electroencephalography equipment market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following product categories:

The conventional EEG systems

The wearable EEG systems

The market is divided into the following segments based on technology:

Routine EEG

EEG video-telemetry

EEG ambulatory monitoring

Sleep deprived EEG

Technavio’s report, Global Electroencephalography Equipment Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, EMEA, and the America; it also covers the landscape of the global electroencephalography equipment market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

Americas

APAC

EMEA

Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=419410

Key vendors

Compumedics

Natus Medical

Nihon Kohden

Philips

Other prominent vendors

Advanced Brain Monitoring

Allengers Medical Systems

Blackrock NeuroMed

Cadwell

Clarity Medical

Clinical Science Systems

Contec Medical Systems

Deymed Diagnostic

EBNeuro

Electrical Geodesics

Elmiko

EMS Biomedical

Integra LifeSciences

LABandTECH

LifeLines Neurodiagnostic Systems

Masimo

Mega Electronics

Mega Med

Micromed

Mitsar

Moberg Research

neuroConn

Neuroelectrics

NeuroSky

Neurosoft

Neurovirtual

NeuroWave Systems

NR Sign

Recorders & Medicare Systems

SIGMA Medizin-Technik

Zynex NeuroDiagnostics

Key market driver

Increasing incidence of epilepsy disorder

For a full, detailed list, view our report

Key market challenge

Availability of alternative technologies

For a full, detailed list, view our report

Key market trend

Increased use of EEG in neuromarketing

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=419410

Table of Content

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by type

PART 07: Market segmentation by application

PART 08: Market segmentation by technology

Browse All Medical Equipments Market Research Reports at: http://www.researchmoz.us/medical-equipments-market-reports-109.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/